Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! For Women With Node-Negative, ER-positive Breast Cancer: Results From NSABP B-14 and NSABP B-20
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-1331-z
Full Text
Open PDFAbstract
Available in full text
Date
January 11, 2011
Authors
Publisher
Springer Science and Business Media LLC